Aims-To study the distribution of tenascin by immunocytochemistry in autoimmune diseases of the thyroid. Methods-Thyroids from patients with inflammatory lesions of the thyroid (lymphocytic thyroiditis Hashimoto, Grave's disease, thyroiditis DeQuervain) were studied by immunocytochemistry using antibodies against tenascin, collagen III, and collagen IV.
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Aims-To study the distribution of tenascin by immunocytochemistry in autoimmune diseases of the thyroid. Methods-Thyroids from patients with inflammatory lesions of the thyroid (lymphocytic thyroiditis Hashimoto, Grave's disease, thyroiditis DeQuervain) were studied by immunocytochemistry using antibodies against tenascin, collagen III, and collagen IV. Results-In autoimmune lymphocytic thyroiditis Hashimoto there was a characteristic corona-like staining pattern of tenascin around all activated lymph follicles with germinal centres. This staining pattern contrasted with the immunoreactions for collagen III and IV, which were not enhanced in the perilymphofollicular interstitium. In cases of thyroiditis DeQuervain the areas of early and ongoing fibrosis showed some diffuse staining for tenascin and for collagen III. Enhanced diffuse immunostaining for collagen IV in the perivascular and interfollicular interstitium was present in cases of Grave's disease. In Grave's disease no characteristic immunoreaction was DeQuervain. 
If the diagnosis of thyroiditis is first made by histopathological examination of the resected thyroid gland, the postoperative determination of endocrinological parameters with regard to autoimmune disease will be of limited value. Therefore it is necessary to look for histological or immunohistochemical parameters to differentiate between mainly autoimmunological processes and other inflammatory diseases in the thyroid itself. With regard to the characteristic corona-like pattern of immunoreactivity for tenascin, immunostaining for tenascin could be an adjunct in the diagnosis of so far not detected or not suspected autoimmune lymphocytic thyroiditis. Other forms of inflammatory diseases can be distinguished by their negative or for instance diffuse immunostaining for tenascin in cases of thyroiditis DeQuervain. In our study Grave's disease did not show a prominent staining for tenascin but had a prominent perivascular and interstitial staining for collagen type IV.
On behalf of a distinct clinical setting a special subtype of thyroiditis with endocrine alterations has been separated-postpartum thyroiditis.'7 '8 By chance we could study one case of postpartum thyroiditis, which is in general not an indication for surgery if suspected preoperatively. Immunohistologically this case showed no corona-like staining for tenascin around lymph follicles. However, further studies on larger series of postpartum thyroiditis will have to clarify whether the expression of tenascin is different in this particular disease of the thyroid.
Immunohistochemically we found a weak reaction in germinal centres with an antibody to TGF-,B3, which cross reacts with TGF-P2.
On paraffin wax sections this relatively weak immunoreaction did not allow a sufficient differentiation of the cellular location in the germinal centres. As the stimulation of tenascin synthesis by TGF-P has been demonstrated in vitro9 this could be one possible mechanism for the re-expression of tenascin in lymphocytic thyroiditis Hashimoto. The presence of growth factors of the TGF-1 family has previously been shown in activated lymphatic tissue by Andersson and coworkers. 9 It is our hypothesis that this might be one pathogenetic explanation for the tenascin expression around activated lymph follicles in lymphocytic thyroiditis. Further investigations are necessary to provide more evidence for the role of TGF-1 in thyroid disease.
The perifollicular deposits of tenascin in our opinion influence the mobility of lymphocytes and monocytes by their antiadhesive properties. The altered matrix composition could theoretically facilitate the expansion of autoimmunologically activated lymphocytes in the thyroid by these antiadhesive properties of the tenascin sheaths. On the other hand, tenascin hinders T cell activation by soluble antigens as shown by in vitro studies. '3 Possibly such a tenascin sheath around the lymph follicles protects the surrounding tissue of the thyroid from a progression of autoreactive lymphocyte clones resulting in a deceleration of an autoimmunological reaction. Most probably the effect of tenascin ambiguously effects both expansion and deceleration of lymphocytes depending on the setting of integrins and integrin receptors on effector cells and stromal cells. Therefore our findings argue for an immunomodulatory role of tenascin in lymphocytic thyroiditis, which clinically is known to have a prolonged and slowly progressive course. 3 20 Similarly lymphofollicular hyperplasia of the thymus in the setting of myasthenia gravis previously has been reported to show perifollicular tenascin deposition.'0 Therefore the characteristic perifollicular accumulation of tenascin around activated lymph follicles can serve as an indicator of an autoimmunologically mediated tissue alteration at least in thyroid and thymic tissue.
